کاردیوپاتی ها (آسیب های ماهیچه قلب) – از پژوهش بنیادی تا مدیریت بالینی Cardiomyopathies - From Basic Research to Clinical Management

Cardiomyopathies - From Basic Research to Clinical Management

This book provides a comprehensive, state-of-the-art review of the current knowledge of cardiomyopathies. Instead of following the classic interdisciplinary division, the entire cardiovascular system is presented as a functional unity, and the contributors explore pathophysiological mechanisms from different perspectives, including genetics, molecular biology, electrophysiology, invasive and non-invasive cardiology, imaging methods and surgery. In order to provide a balanced medical view, this book was edited by a clinical cardiologist.
Contents:
-- Part 1 Classification, Evaluation and Management of Cardiomyopathies -- 1 Classification and Definitions of Cardiomyopathies -- 2 Management of Hypertrophic Obstructive Cardiomyopathy with a Focus on Alcohol Septal Ablation -- 3 Hypertrophic Cardiomyopathy in Infants and Children -- 4 Quality of Life in Dilated Cardiomyopathy with Refractory Chronic Heart Failure Undergoing Devices Implantation -- 5 Periparturn Cardiomyopathy: A Systematic Review -- 6 Cardiomyopathy Detection from Electrocardiogram Features -- 7 Prevention of Sudden Cardiac Death in Patients with Cardiomyopathy -- 3 Bio marker for Cardiomyopathy-B-Type Natriuretic Peptide -- Part 2 Pathophysiology and Genetics of Cardiomyopathies -- 9 Heart Muscle and Apoptosis -- 10 Cardiac Myocytes and Mechanosensation -- 11 Dobuta mine-induced Mechanical A Iter nans -- 12 MicroRNAs Telltale Effects on Signaling Networks in Cardiomyopathy -- 13 Intercellular Connections in the Heart: The Intercalated Disc -- 14 Familial Hypertrophic Cardiomyopathy-Related Troponin Mutations and Sudden Cardiac Death -- 15 Consequences of Mutations in Genes Encoding Cardiac Troponin C, T and I - Molecular Insights -- 16 Cardiomyopathies Associated with Myofibrillar Myopathies -- 17 Functional Consequences of Mutations in the Myosin Regulatory Light Chain Associated with Hypertrophic Cardiomyopathy -- 18 Role of Genetic Factors in Dilated Cardiomyopathy -- Part 3 Cardiomyopathies and Imaging Methods -- 19 Role of Advanced Cardiac Magnetic Resonance Imaging in Atypical Cardiomyopathies such as Stress-Induced Cardiomyopathie and Left-Ventricular Non-Compaction Cardiomyopathy -- 20 The Use of Contrast-Enhancement Cardiovascular Magnetic Resonance Imaging in Cardiomyopathies -- Part 4 Metabolic and Drug-Induced Cardiomyopathies -- 21 The Evolving Face of Heart Failure Associated with Elevated Cardio-Metabolie Risk Factors -- 22 Diabetic Cardiomyopathy: Cardiac Changes. Pathophvsiological Mechanisms. Biologic Markers, and the Available Therapeutic Armamentarium -- 23 Insulin Resistance and Cardiomyopathy -- 24 Taurine Depletion-Related Cardiomyopathy in Animals -- 25 Thyrotoxic Cardiomyopathy -- 26 Drug-Induced Cardiomyopathies -- 27 Anthracycline Cardiotoxicity -- 28 Cardiotonic Steroids and Cardiac Fibrosis -- Part 5 Takotsubo Cardiomyopathy -- 29 Stress-Induced Cardiomyopathy: Clinical Observations -- 30 Takotsubo Cardiomyopathy -- 31 Pathology of Takotsubo (Ampulla) Cardiomyopathy -- 32 Torsades de Pointes in Takotsubo Cardiomyopathy with QT Prolongation -- 33 Torsades de Pointes Associated with Takotsubo Cardiomyopathy: Is It Preventable? -- Part 6 Chagas Heart Disease -- 34 Chagas Heart Disease -- 35 Chagasic Cardiomyopathy